检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刁海彦[1] 姜宁[2] 王国增[2] 马杰[2] 郑景存[2] 章璟[2] 冯彬[1]
机构地区:[1]宁夏医科大学,银川750004 [2]上海市浦东新区公利医院,上海200129
出 处:《宁夏医科大学学报》2012年第6期581-584,591,共5页Journal of Ningxia Medical University
基 金:上海市浦东新区社会发展局卫生科技项目(PW2009A-8)
摘 要:目的检测microRNA-21(miR-21)与microRNA-205(miR-205)在初、复发膀胱尿路上皮癌中的表达情况,探讨microRNAs(miRNAs)在膀胱尿路上皮癌中的表达意义及是否与肌层浸润有关。方法采用基于2-△△CT的实时定量PCR(Real-time PCR)方法检测40例初、复发癌组织miR-21及miR-205的表达情况。结果与初发癌相比,复发癌miR-21表达上调(P<0.05),miR-205表达下调(P<0.05);与非肌层浸润性癌相比,肌层浸润性癌miR-21表达上调(P<0.05),miR-205表达下调(P<0.05);肌层浸润性癌miR-21与miR-205表达量的比值5倍于其在非肌层浸润性癌中表达量的比值。结论 miR-21高表达、miR-205低表达可能参与膀胱尿路上皮癌复发并与肌层浸润有关。Objective To detect the expressions of miR -21 and miR -205 in maiden and recurrence bladder urothelial cell carcinoma and to explore the relationship between microlRNAs(miRNAs) and muscle -invasion in urothelial cell carcinoma of bladder. Methods 2- ΔCT Real -time PCR method was used for quantitative analysis of the expression of miR - 21 and miR - 205 in 40 patients with maiden and recurrence urothelial cell carcinoma of bladder. Results Compared with maiden tissues, the recurrence tissues showed significant miR - 21 over - expression ( P 〈 0.05 ) and miR - 205 down - regulation ( P 〈 0.05 ) ; Compared with non muscle - invasive bladder cancer, muscle - invasive bladder cancer showed significant miR - 21 over - expres- sion ( P 〈 0.05 ) and miR - 205 down - regulation( P 〈 0.05 ) ; both maiden and recurrence cancer character- ized as muscle - invasive bladder showed a miR - 21 : miR - 205 ratio at least 5 - fold higher than the quantita- tive ratio obtained from non muscle - invasive bladder. Conclusion The over expression of miR - 21 and lower expression of miR -205 may participate in recurrence urothelial cell carcinoma of bladder and have rela- tionship with muscle invasive.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117